Therapeutic drug monitoring of plasma fluvoxamine levels for treating bulimia nervosa.
Ikenouchi-Sugita
Atsuko
A
Yoshimura
Reiji
R
Hori
Hikaru
H
Ueda
Nobuhisa
N
Nakamura
Jun
J
D000293:Adolescent; D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000097:blood* / Q000627:therapeutic use*; D052018:Bulimia Nervosa / Q000188:drug therapy* / Q000523:psychology; D003863:Depression / Q000150:complications / Q000523:psychology; D016903:Drug Monitoring; D005260:Female; D016666:Fluvoxamine / Q000008:administration & dosage / Q000097:blood* / Q000627:therapeutic use*; D006801:Humans; D011569:Psychiatric Status Rating Scales
D018687:Antidepressive Agents, Second-Generation; D016666:Fluvoxamine